Compare DRK & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRK | FLNA |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | 20 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.9M | 30.0M |
| IPO Year | 2020 | 2000 |
| Metric | DRK | FLNA |
|---|---|---|
| Price | $1.76 | $0.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.50 | ★ $6.50 |
| AVG Volume (30 Days) | 134.3K | ★ 489.7K |
| Earning Date | 11-10-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,181,000.00 | ★ $41,119,000.00 |
| Revenue This Year | $30.56 | N/A |
| Revenue Next Year | $1.13 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.88 | $0.60 |
| 52 Week High | $3.27 | $2.03 |
| Indicator | DRK | FLNA |
|---|---|---|
| Relative Strength Index (RSI) | 21.48 | 35.57 |
| Support Level | N/A | N/A |
| Resistance Level | $2.95 | $1.05 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 5.88 | 11.40 |
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.